Delivery Order SPE2DR25D2003-SPE2DR26FR10Y
Award Date 1/15/26
Potential Completion Date 1/16/26
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $3,712.40 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of December 1, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- AmerisourceBergen Drug Corp received a $5,814.64 delivery order from the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with an ultimate completion date of August 19, 2025. The pharmaceutical products will be delivered to the DLA's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with a ceiling value of $1,354.88 and an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $1,970.02 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This firm fixed-price contract, awarded on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a competitive award with no set-aside designation. The delivery order is issued under AmerisourceBergen's broader Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on December 22, 2025, for NovoLog 100 Unit/mL FlexPen 3mL insulin pens valued at $1,278.98. This is a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and the work will be performed at the contractor's Conshohocken facility. The award utilizes no set-aside designation and was competitively awarded through the federal...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,405.80 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively as a child contract under AmerisourceBergen's larger DLA prime vendor contract vehicle. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens with a ceiling value of $1,636.80. The contract was competitively awarded without set-aside designation and is classified as a Firm Fixed Price delivery order, with an ultimate completion date of October 27, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,175.60 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens under a firm fixed-price contract. The award, issued December 31, 2025, with completion targeted for January 2, 2026, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,893.22 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of December 3, 2025. This is a firm fixed-price, non-set-aside contract issued as a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,792.62 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...